Insulatard® (isophane insulin, human) Penfill® 100units/ml suspension for injection 3ml cartridges are being discontinued; stock is anticipated to be exhausted by June 2025. 

Humulin® I KwikPen® (isophane insulin, human) 100units/ml suspension for injection 3ml pre-filled pens are available and can support a full increase in demand. 

Humulin® I (isophane insulin, human) 100units/ml suspension for injection 3ml cartridges are available but cannot support an increase in demand. 

TO NOTE: This is the second of three MSANs covering discontinuations of Novo Nordisk insulin products (NovoRapid® FlexTouch®, Insulatard® Penfill® and all Levemir® presentations). A third MSAN will provide clinical advice on the discontinuation of all Levemir® presentations. Clinicians should not initiate new patients on Levemir® or make any switches from Levemir® to alternative insulins at this time. It should be noted that where alternative insulin products have been recommended, consideration has been made both to these product discontinuations, and availability of other insulin products.